FIELD: pharmacology. SUBSTANCE: total content of triterpene glycosides from azure teasel is used as an agent showing holagogue and hepatoprotective effects. This substance can be used in clinics in the future. EFFECT: detection of agent indicated above. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL AGENT WITH HEPATOPROTECTIVE, CHOLERETIC AND SPASMOLYTIC ACTION | 2007 |
|
RU2326686C1 |
| HEPATOPROTECTIVE AND ANTIHEPATOTOXIC PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING HEPATIC DISEASES THAT INVOLVES INTRODUCTION OF SAID COMPOSITION | 2008 |
|
RU2381800C1 |
| METHOD OF PRODUCING AN AGENT POSSESSING ANTIOXIDANT, HEPATOPROTECTIVE AND CHOLERETIC ACTIVITY | 2019 |
|
RU2715274C1 |
| METHOD TO OBTAIN 1-HYDROXY-2,3,4,5-TETRAMETOXYXANTHONE OF CHOLAGOGUE AND HEPATOPROTECTIVE ACTION | 2000 |
|
RU2178302C1 |
| METHOD FOR PREPARING MEDICINAL PRODUCT POSSESSING CHOLERETIC, ANTI-INFLAMMATORY ACTIVITIES | 2014 |
|
RU2557990C1 |
| COMBINED AGENT CONTAINING UDCA, HYMECROMONE AND SILYMARIN (VERSIONS) | 2017 |
|
RU2738444C2 |
| METHOD FOR PREPARING AGENT HAVING HEPATOPROTECTIVE AND CHOLERETIC EFFECT | 2023 |
|
RU2828000C1 |
| HERBAL AGENT POSSESSING HEPATOPROTECTIVE ACTION | 2014 |
|
RU2554493C1 |
| METHOD OF PREPARING OF AGENT SHOWING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC EFFECT | 1991 |
|
RU2011383C1 |
| AGENT WITH HEPATOPROTECTIVE AND CHOLAGOSTIC ACTION | 2005 |
|
RU2296579C1 |
